US 10077424
Methods of producing RPE cells and compositions of RPE cells
granted A61KA61K35/12A61K35/30
Quick answer
US patent 10077424 (Methods of producing RPE cells and compositions of RPE cells) held by Astellas Institute for Regenerative Medicine expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Astellas Institute for Regenerative Medicine
- Grant date
- Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K35/12, A61K35/30, A61P, A61P25/16